Nihon Kohden Corporation (TYO:6849)
| Market Cap | 249.64B -12.6% |
| Revenue (ttm) | 232.48B +1.4% |
| Net Income | 13.62B +1.1% |
| EPS | 84.16 +3.1% |
| Shares Out | 159.97M |
| PE Ratio | 18.54 |
| Forward PE | 16.66 |
| Dividend | 33.00 (2.18%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 538,800 |
| Open | 1,565.00 |
| Previous Close | 1,558.00 |
| Day's Range | 1,555.50 - 1,571.50 |
| 52-Week Range | 1,323.00 - 1,885.50 |
| Beta | 0.37 |
| Analysts | Hold |
| Price Target | 1,800.00 (+15.35%) |
| Earnings Date | Nov 10, 2026 |
About Nihon Kohden
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors, including central monitors, bedsid... [Read more]
Financial Performance
In fiscal year 2026, Nihon Kohden's revenue was 235.10 billion, an increase of 4.29% compared to the previous year's 225.42 billion. Earnings were 14.51 billion, an increase of 2.94%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for 6849 stock is "Hold." The 12-month stock price target is ¥1,800, which is an increase of 15.35% from the latest price.
News
Nihon Kohden Expands Executive Leadership to Support Continued Growth and Customer Experience
IRVINE, Calif.--(BUSINESS WIRE)-- #ExecutiveLeadership--Nihon Kohden, a leading provider of patient monitoring, neurology, ventilation and digital health solutions, today announced an expanded executi...
Nihon Kohden Slides: Q1 2027
Nihon Kohden has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 6, 2026.
Nihon Kohden Quarterly report: Q1 2027
Nihon Kohden has published its Q1 2027 quarterly earnings report on August 6, 2026.
Nihon Kohden Upgrades NKV-550, Now First Ventilator Combining Non-Invasive Muscle Pressure Monitoring, AVM and Adjustable AdaptiveSync™ Manufactured in the U.S.
IRVINE, Calif.--(BUSINESS WIRE)-- #CriticalCare--Nihon Kohden America today announced three advanced capabilities now available on the NKV-550 Series Ventilator System. Non-invasive Muscle Pressure (P...
Nihon Kohden Slides: Q4 2026
Nihon Kohden has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.
Nihon Kohden Quarterly report: Q4 2026
Nihon Kohden has published its Q4 2026 quarterly earnings report on May 14, 2026.
Nihon Kohden Brings NomadAir® with Connect to Dental Sleep Medicine, Connecting Providers for Faster, Smarter Care
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic, patient, monitoring and ventilation, today announced it is expanding the reach of NomadAir® with Connect — its establ...
Nihon Kohden Quarterly report: Q3 2026
Nihon Kohden has published its Q3 2026 quarterly earnings report on February 5, 2026.
Nihon Kohden Slides: Q3 2026
Nihon Kohden has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 5, 2026.
Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, hel...
Nihon Kohden Slides: Q2 2026
Nihon Kohden has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 10, 2025.
Nihon Kohden Quarterly report: Q2 2026
Nihon Kohden has published its Q2 2026 quarterly earnings report on November 10, 2025.